BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21117918)

  • 21. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy.
    Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K
    Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
    Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced growth hormone secretion after cranial irradiation contributes to neurocognitive dysfunction.
    Quik EH; Valk GD; Drent ML; Stalpers LJ; Kenemans JL; Koppeschaar HP; van Dam PS
    Growth Horm IGF Res; 2012 Feb; 22(1):42-7. PubMed ID: 22269954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GH deficiency as the most common pituitary defect after TBI: clinical implications.
    Popovic V
    Pituitary; 2005; 8(3-4):239-43. PubMed ID: 16508711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in BMI and management of patients with childhood onset growth hormone deficiency in the transition phase.
    Bazarra-Castro MÁ; Sievers C; Schwarz HP; Pozza SB; Stalla GK
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):507-10. PubMed ID: 23070828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation.
    Elbornsson M; Götherström G; Bengtsson BÅ; Johannsson G; Svensson J
    Growth Horm IGF Res; 2013 Dec; 23(6):249-55. PubMed ID: 24103227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone replacement therapy in patients with traumatic brain injury.
    Moreau OK; Cortet-Rudelli C; Yollin E; Merlen E; Daveluy W; Rousseaux M
    J Neurotrauma; 2013 Jun; 30(11):998-1006. PubMed ID: 23323993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G; Sunnerhagen KS; Svensson J
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive deterioration due to GH deficiency in patients with traumatic brain injury: a preliminary report.
    León-Carrión J; Leal-Cerro A; Cabezas FM; Atutxa AM; Gomez SG; Cordero JM; Moreno AS; Ferrari MD; Domínguez-Morales MR
    Brain Inj; 2007 Jul; 21(8):871-5. PubMed ID: 17676444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study.
    Huisman J; Aukema EJ; Deijen JB; van Coeverden SC; Kaspers GJ; van der Pal HJ; Delemarre-van de Waal HA
    BMC Pediatr; 2008 Jun; 8():25. PubMed ID: 18570650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: a preliminary study.
    Wamstad JB; Norwood KW; Rogol AD; Gurka MJ; Deboer MD; Blackman JA; Buck ML; Kuperminc MN; Darring JG; Patrick PD
    Brain Inj; 2013; 27(2):200-8. PubMed ID: 23384217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognition in the adult with childhood-onset GH deficiency.
    van Nieuwpoort IC; Drent ML
    Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S53-7. PubMed ID: 18787050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress.
    Popovic V; Pekic S; Pavlovic D; Maric N; Jasovic-Gasic M; Djurovic B; Medic Stojanoska M; Zivkovic V; Stojanovic M; Doknic M; Milic N; Djurovic M; Dieguez C; Casanueva FF
    J Endocrinol Invest; 2004 Dec; 27(11):1048-54. PubMed ID: 15754737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Prevalence of Isolated Growth Hormone Deficiency in Patients After Brain Injury: Results From a Phase II Pilot Study.
    Leonhardt M; Kopczak A; Schäpers B; Limbrock J; Sämann PG; Czisch M; von Steinbuechel N; Jordan M; Schneider HJ; Schneider M; Sievers C; Stalla GK
    Front Endocrinol (Lausanne); 2018; 9():723. PubMed ID: 30619080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone deficiency after mild combat-related traumatic brain injury.
    Ioachimescu AG; Hampstead BM; Moore A; Burgess E; Phillips LS
    Pituitary; 2015 Aug; 18(4):535-41. PubMed ID: 25266761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.